Objective: To evaluate the pregnancy and delivery outcome of robot-assisted tubal reanastomosis.
Design: Retrospective cohort study.
Setting: University hospital.
Patient(s): Ninety-seven patients with available follow-up who underwent the reversal of tubal ligation, with a median age of 37 years (range, 24-47 years).
Intervention(s): Tubal reanastomosis by robot-assisted laparoscopy.
Main Outcome Measure(s): Analysis of the distribution of time to conception and to estimate the crude pregnancy and birth rates at 2 years.
Result(s): The overall pregnancy and birth rates were 71%, (95% confidence interval [CI], 61%-80%) and 62% (95% CI, 52%-72%). Ninety-one percent (95% CI, 76%-98%) of patients <35 years old became pregnant, and 88% (95% CI, 72%-97%) delivered at least once. The corresponding pregnancy and delivery rates were 75% (95% CI, 57%-89%) and 66% (95% CI, 47%-81%) between 36 and 39 years old, 50% (95% CI, 25%-75%) and 43.8% (95% CI, 20%-70%) between 40 and 42 years old, 33% (95% CI, 10%-65%) and 8.3% (95% CI, <1%-38%) after the age of 43 years.
Conclusion(s): This study reports satisfactory birth rates after tubal reanastomosis by robot-assisted laparoscopy in patients aged 40 years or less.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.fertnstert.2009.10.028 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Laparoscopic robotic assisted surgery in reproductive medicine.
Arch Med Res
November 2024
Department of Obstetrics and Gynecology, Southern Illinois University, Springfield, Illinois, USA. Electronic address:
Article Synopsis
- Laparoscopic Robot-assisted surgery is a cutting-edge advancement in surgical technology, particularly benefiting reproductive medicine by enhancing fertility and providing innovative treatment options for gynecological conditions.
- Compared to traditional open surgery, it offers reduced post-surgical hospital stays and blood loss, with mixed results on operative times due to varying surgeon experience.
- Despite challenges like high costs and lack of tactile feedback, recent improvements—including the integration of Artificial Intelligence—are enhancing its applications for fertility preservation in female cancer survivors and other reproductive surgeries.
[Desire to have children after vasectomy : Vasectomy reversal or assisted reproductive technology?].
Urologie
November 2024
Abteilung für Klinische und Operative Andrologie, Centrum für Reproduktionsmedizin und Andrologie, WHO Kooperationszentrum und Ausbildungszentrum der Europäischen Akademie für Andrologie, Universitätsklinikum Münster, Münster, Deutschland.
The vasectomy is a safe and effective method of contraception for men. Up to 6% of men who underwent vasectomy have a renewed child wish. Microsurgical vasectomy reversal (VR) in men, microsurgical epididymal sperm aspiration (MESA), or testicular sperm extraction (TESE) in men plus assisted reproductive technology (ART) in the female partner as well as the combination of VR and MESA/TESE plus ART represent established therapeutic strategies.
View Article and Find Full Text PDFPregnancy after Tubal Sterilization in the United States, 2002 to 2015.
NEJM Evid
September 2024
DuPont Clinic and Department of Population, Family, and Reproductive Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore.
Article Synopsis
- Tubal sterilization is the leading contraceptive method in the U.S., and this study investigates the rates of pregnancy following the procedure using data from the National Survey of Family Growth over various years.
- Results indicate that 2.9 to 5.2% of participants reported pregnancies after tubal sterilization, with lower rates associated with postpartum procedures compared to interval procedures, although this was not consistent in all analyses.
- The study found that older age at the time of sterilization decreased the likelihood of pregnancy, while factors such as race/ethnicity, education, and Medicaid funding did not have consistent impacts on post-sterilization pregnancy rates.
Factors affecting patency time and semen quality in a single-armed microsurgical vasoepididymostomy.
Asian J Androl
November 2024
Department of Andrology and Sexual Medicine, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Although microsurgical vasoepididymostomy (MVE) is an effective treatment for epididymal obstructive azoospermia, some patients may experience delayed patency or suboptimal semen parameters after patency. However, research into patency time, semen quality postpatency, and associated influencing factors remains limited. This study aimed to address these issues by evaluating 181 patients who underwent at least one-sided MVE employing asingle-armed longitudinal intussusception vasoepididymostomy technique, with a follow-up period of over 12 months for 150 patients.
View Article and Find Full Text PDFWhere Microsurgical Tubal Reanastomosis Stands in the Fertilization Era.
Gynecol Minim Invasive Ther
May 2024
Department of Obstetrics and Gynecology, Center for Minimally Invasive Surgery and Treatment, Good Moonhwa Hospital, Busan, Korea.
Among various options of contraception, bilateral tubal ligation (BTL) remains the most frequently used method for women worldwide even at present. However, up to 30% of those who undergo BTL eventually change their minds and wish to conceive again for a variety of reasons, such as a change in marital status or simply wanting more children. In this case, we can either approach it surgically with tubal re-anastomosis (TA) or by fertilization (IVF)-embryo transfer.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!